These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33586878)

  • 1. Non-Langerhans cell histiocytosis xanthogranuloma patient with varying histopathology leading to progressive nodular histiocytosis.
    Oh Y; Kim J; Park CO
    J Dtsch Dermatol Ges; 2021 Feb; 19(2):282-285. PubMed ID: 33586878
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case with Juvenile Xanthogranuloma and Progressive Nodular Histiocytosis Overlap.
    Guidolin L; Noguera-Morel L; Hernández-Martín A; Fernández-Llaca H; Rodríguez-Peralto JL; Torrelo A
    Pediatr Dermatol; 2017 Mar; 34(2):e102-e103. PubMed ID: 28297144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histopathology of Langerhans cell histiocytosis.
    Favara BE; Jaffe R
    Br J Cancer Suppl; 1994 Sep; 23():S17-23. PubMed ID: 7521200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive nodular histiocytosis with normal karyotypic analysis.
    Amin SM; Riddle C; Fraga GR; Coquilla-Canete B; Cherian R; McGregor D
    Dermatol Online J; 2013 Jun; 19(6):18577. PubMed ID: 24011326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-Langerhans' cell histiocytoses in childhood.
    Burgdorf WH; Zelger B
    Cutis; 1996 Sep; 58(3):201-7. PubMed ID: 8886534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign cephalic histiocytosis progressing into juvenile xanthogranuloma: a non-Langerhans cell histiocytosis transforming under the influence of a virus?
    Rodriguez-Jurado R; Duran-McKinster C; Ruiz-Maldonado R
    Am J Dermatopathol; 2000 Feb; 22(1):70-4. PubMed ID: 10698221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile xanthogranuloma versus Langerhans cell histiocytosis (histiocytosis X).
    Lazova R; Shapiro PE
    Semin Cutan Med Surg; 1999 Mar; 18(1):71-7. PubMed ID: 10188845
    [No Abstract]   [Full Text] [Related]  

  • 9. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
    Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
    Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of congenital systemic juvenile xanthogranulomatosis with pulmonary involvement.
    Ataseven E; Kizmazoglu D; Oniz H
    Pediatr Dermatol; 2021 Jul; 38(4):892-894. PubMed ID: 33998710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Generalized eruptive histiocytosis-Juvenile xanthogranuloma: clinical spectrum in a pediatric patient].
    Alperovich R; Grassino PT; Asial R; Pasteris L; Boente MD
    Arch Argent Pediatr; 2017 Apr; 115(2):e116-e119. PubMed ID: 28318197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile Xanthogranuloma in a Pediatric Patient with Langerhans Cell Histiocytosis.
    Ram R; Marolf MD; Chévez-Barrios P; Herce HH
    Ocul Oncol Pathol; 2018 Apr; 4(3):141-144. PubMed ID: 29765943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Xanthogranuloma: An Entity With a Wide Clinical Spectrum.
    Hernández-San Martín MJ; Vargas-Mora P; Aranibar L
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):725-733. PubMed ID: 32721389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive nodular histiocytosis--rare variant of cutaneous non-Langerhans cell histiocytosis].
    Lüftl M; Seybold H; Simon M; Burgdorf W
    J Dtsch Dermatol Ges; 2006 Mar; 4(3):236-8. PubMed ID: 16626320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A child with coexistent juvenile xanthogranuloma and Langerhans cell histiocytosis.
    Yu H; Kong J; Gu Y; Ling B; Xi Z; Yao Z
    J Am Acad Dermatol; 2010 Feb; 62(2):329-32. PubMed ID: 19969387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is disseminated juvenile xanthogranulomatosis benign cephalic histiocytosis?
    Sidwell RU; Francis N; Slater DN; Mayou SC
    Pediatr Dermatol; 2005; 22(1):40-3. PubMed ID: 15660896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Cyclin D1 in Cutaneous Xanthogranuloma and Solitary Reticulohistiocytoma.
    Saggini A; Cerroni L; Ortins-Pina A; Kraft S
    Am J Dermatopathol; 2023 Mar; 45(3):208-210. PubMed ID: 36730793
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma.
    Mavi ME; Turan BS; Salanci BV; Bozkurt MF
    Clin Nucl Med; 2022 May; 47(5):e395-e396. PubMed ID: 35085175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive nodular histiocytosis: a case report with literature review, and discussion of differential diagnosis and classification.
    Glavin FL; Chhatwall H; Karimi K
    J Cutan Pathol; 2009 Dec; 36(12):1286-92. PubMed ID: 19878386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthogranuloma is the archetype of non-Langerhans cell histiocytoses.
    Zelger BW; Cerio R
    Br J Dermatol; 2001 Aug; 145(2):369-71. PubMed ID: 11531823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.